Increasing Volume and Decreasing Value

Objectives of the Study

Rationale for M&As

The challenges posed by expiring patents, the global economic slowdown, generic competition, reduced healthcare spending, and price premium pressures are forcing the pharma and biotech industry to restructure and streamline strategies to increase profitability. M&As have become key for the reversal of reduced profitability by opening access to new markets while creating more revenue pools and to some extent compensating for the depletion of the R&D pipeline.

Key Trends

- Big pharma’s contribution to M&A deal value has been decreasing, unlocking big pharma’s inability to participate in high-value deals over the past few years.
- The trend of increasing low-value deals is expected to continue. However, big pharma’s balance sheets show signs of a few mega deals.
- North America remains the most active region in terms of both number and value of deals.
- The pharmaceutical and biotechnology stock market indices continue to outperform the S&P 500 index.
- Biotechnology deals witnessed higher stock premiums compared to the pharmaceutical sector.
- Horizontal integration remains key in both the pharmaceutical and biotechnology sectors.

Key Terms Used in the Study

Transactions
- M&A: Mergers and acquisitions is an aspect of corporate strategy, corporate finance, and management by which corporations legally unify ownership of assets formerly subject to separate controls. The term “deal” in the study refers to M&A transactions.
- The Industry is comprised of 2 sectors, pharmaceutical and biotechnology.

Sector
- Pharmaceutical: Companies engaged in the research, development, or production of pharmaceuticals.
- Biotechnology: Companies primarily engaged in the research, development, manufacture, and/or marketing of products based on genetic analysis and genetic engineering. This includes companies specializing in protein-based therapeutics to treat human diseases.

Big Pharma
The collective term referring to the largest participants in terms of revenue in the pharmaceutical sector. The list of companies included in this study is provided in the glossary.

Big Biotech
The collective term referring to the largest participants in terms of revenue in the biotechnology sector. The list of companies included in this study is provided in the glossary.

Study’s Key Objectives Include:
- Analyzing the mergers and acquisitions (M&A) trends in the global pharma and biotech industry
- Identifying the key M&A trends in the industry based on geographies, deals across sectors, and the natures of buyers
- Conducting a financial analysis of the deals with respect to valuation multiples
- Identifying, comparing, and assessing geographical regions that have current and potential M&A activity
- To arrive at strategic conclusions based on the key trends observed

Analysis Includes

- Across sectors
- Across geographies
- Valuation multiples
- Stock price variations
- Percentage of stake acquired
- Type of buyers

Who will benefit?

- Companies operating in the global pharma and biotech industry
- Private equity
- Venture capital investors
- Fund managers
- Retail investors
- Sovereign wealth funds
- Hedge funds
- Insurance funds and other members in the investing community

Table Of Contents

Executive Summary
Introduction
The Key Rationale for MandA
Key MandA Indicators
Geographic Analysis
Cross-border Deal Analysis—Buyer’s Perspective for Asia-Pacific, Europe, and North America
Sectorial Analysis—Pharmaceutical
Sectorial Analysis—Biotechnology
Percent Stake Sought and Target Stock Premium Analysis
Conclusion
Appendix
The Frost and Sullivan Story

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Investment Opportunity in the Global Biofuels Energy Market

Investment Opportunity in the Global Biofuels Energy Market

  • $ 7 500
  • Industry report
  • April 2014
  • by Frost & Sullivan

The research service for the investment opportunity in biofuels energy focuses on the investments and funding patterns in global biofuels energy companies. The study identifies historical trends in bioethanol, ...

Vertical-Cavity Surface-Emitting Lasers (VCSEL) : Technologies and Global Markets

Vertical-Cavity Surface-Emitting Lasers (VCSEL) : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

The use of vertical-cavity surface-emitting lasers (VCSELs) has increased in the optical communications industry in the past 15 years. This spurring demand can be attributed to the increasing demand of ...

Merger and Acquisition Trends in the Global Food and Beverage Industry

Merger and Acquisition Trends in the Global Food and Beverage Industry

  • $ 6 000
  • Industry report
  • May 2014
  • by Frost & Sullivan

Average Deal Values are on the Rise This study analyzes the merger and acquisition (M&A) transactions that have taken place in the global food and beverage industry between January 2007 and December 2013. ...

Insight Report: Angel Investors

April 2014 $ 3 800

Telco Cdn

April 2014 $ 1 875

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.